Assessing Barriers to Clinical Trial Enrollment

Barriers to clinical trial (CT) enrollment are well-described in the literature, typically focusing on patient- and physician-related barriers. Usingpublished guidelines for improving CTenrollment, this survey seeks to look at some practical aspects of howCTs are run at centers in the SCOR,in hopes of explaining at least in part why some centers enroll better than others.

Who decides which trials will be opened at your facility?

Do you have a “champion” for each disease site?

Yes

No

If yes, who is it ?

Do you have any industry-sponsored trials competing for the same patients as NCI-sponsored trials?

Yes

No

Before opening a trial, how do you estimate the number of patients you will be able to enroll?

Educated guess.

Analysis of Cancer Registry Data.

Based on enrollment to prior studies.

Other

Do you benchmark your accrual activity ?

Yes

No

Do you have any local or distant competitors in your specialty of practice?

Yes

No

Do you have an active plan to recruit under-represented populations?

Yes

No

Do you have a process in place that automatically screens all patients for clinical trial eligibility?

Yes

No

Assessing Barriers to Clinical Trial Enrollment